Read this article's abstract last week on science.org. It focuses on mitochondria and ER status in animal models and AD patients. In real AD in human patients, it said it found S1 expression is higher in early AD vs mid to late stage, making this a possible future biomarker for diagnosing and monitoring AD.
Market Data 
Markets 
AI
